
Overview
Sally Evans is an Antitrust partner in the London and Brussels offices of Paul Hastings. Sally’s practice focuses on merger control, cartel investigations and compliance advice. She counsels clients on transactional antitrust issues, as well as foreign direct investment (FDI) regimes in the U.K. and elsewhere.
Sally regularly works with the U.K. Competition and Markets Authority and the European Commission. She has experience across a broad range of sectors, from healthcare and pharmaceuticals to retail and industrials, and has secured numerous clearances under various antitrust and FDI regimes.
Prior to joining Paul Hastings, Sally advised on competition law in-house with a leading global oil and gas producer and in the U.K. retail banking sector. She also practiced competition law in Beijing, advising clients on the Chinese merger control process.
Accolades
- Chambers UK 2025 – Competition Law
- Leading Partner, Legal 500 UK – Antitrust and Competition, 2025
- Thought Leader in Competition, Lexology Index, 2026.
- Power Player for Merger Control, Financier Worldwide, 2025
- 40 Under 40, Global Competition Review, 2020
Education
- University of Oxford, BA Jurisprudence (Law), 2004
- Oxford Institute of Legal Practice, Post-graduate Diploma Legal Practice (with distinction), 2005
- King’s College London, Post-graduate Diploma EC Competition Law (with distinction), 2009
Representations
Representative matters prior to joining Paul Hastings include:
Antitrust Investigations and Compliance Advice
- Managing responses to investigations by the European Commission into potential cartel conduct and breaches of Article 101 TFEU in the automotive parts, ethanol and biofuels, credit default swaps, freight forwarding, liquid crystal displays (LCD) and car glass sectors.
- Assisting an investment bank to respond to a conduct investigation by the U.K. Financial Conduct Authority.
- Representing a client in the U.K. aggregates, ready-mix concrete and cement market study and in relation to the cement market investigation.
- Standing antitrust compliance counsel to a client in the software sector, including in relation to abuse of dominance rules.
Public Company Transactions
Managed required antitrust and FDI approvals for:
- Anglo American on their joint venture with Lafarge, subject to a U.K. Phase II review requiring extensive divestments in cement, ready mixed concrete and aggregates.
- Dentsu on the $5 billion global takeover of advertising firm Aegis.
- Greene King on the $1.2 billion takeover of pub chain Spirit, which required a number of pub divestments to secure CMA approval.
- Ingersoll-Rand on the $1.45 billion acquisition of Precision Flow Systems.
- JBT on the sale of its AeroTech business.
- Kier Group on the £221 million public takeover of construction business May Gurney, which received CMA clearance.
- Noble on the combination with Maersk Drilling, subject to Phase I remedies agreed with the CMA.
- Tokio Marine HCC on the acquisition of GCube, a managing general agent in the insurance sector.
- Travelport Worldwide on the $4.4 billion sale to Siris Capital and Elliott Management.
- Tronox on the acquisition of Cristal’s global titanium dioxide business in a transaction valued at approximately $2.2 billion, which was subject to a Phase II remedy in the EU.
- Zebra Technologies on the $1.3 billion acquisition of Elo Touch Solutions and on the acquisition of Reflexis Systems.
Private equity led transactions
Managing required antitrust and FDI approvals for:
- Adenza on the acquisition by NASDAQ for $10.5 billion.
- Ares Management on several transactions, including the acquisition of T.A. Systems.
- Bain Capital on several transactions including the acquisition of Reifen Krieg (resulting in a combination of replacement tire wholesalers) and DSM Sinochem Pharmaceuticals (a producer of sustainable antibiotics, next-generation statins and anti-fungals).
- BC Partners on several transactions, including the sale of a minority stake in PetSmart to asset manager Apollo, the acquisition of Keesing (a leading European braintainment business) and the investment in Advanced (a provider of business software solutions).
- Blackstone Credit & Insurance on the investment in ITE Management.
- Bridgepoint on CMA reviews of two bolt-on acquisitions of U.K. dental chains.
- CapVest and its portfolio company Valeo Foods on the acquisitions of Tangerine Confectionery (the leading supplier of private label sugar confectionery in the U.K.), which received CMA clearance and also on the carve-out acquisition from Mallinckrodt of its global nuclear imaging radiopharmaceuticals division by CapVest’s IBA Molecular, which was cleared on the basis of the de minimis exception by the CMA.
- Centerbridge on the $2 billion acquisition of MeridianLink.
- CITIC on the US$2.08 billion acquisition of the majority stake in the master franchisee for McDonald’s in China and Hong Kong, together with Carlyle.
- EQT on several matters including:
- the €6.8 billion acquisition of Baring Private Equity Asia (a leading private markets investment firm);
- the sale of the EQT Credit business to Bridgepoint;
- an EQT led consortium on the CHF 10.2 billion acquisition of Nestlé Skin Health (a leading global skincare company);
- the sale of a minority stake in Independent Vetcare (IVC) Group to Nestlé SA; and
- the combination of IVC and Evidensia.
- GIC on several matters, including the minority interest acquisition in Messer Group (a supplier of industrial and specialty gases).
- HarbourVest on several fund investments, including the investment in Gatekeeper.
- Hospital Topco (majority owned by Centerbridge and KKR) on U.K. merger control aspects of the £1.8 billion disposal of BMI Healthcare and the GHG Group to Circle Health.
- Madison Dearborn on the combination of Intelligent Packaging Limited (IPL) and Schoeller Allibert (both suppliers of returnable plastic packaging), as well as on the acquisition of NextGen.
- Oaktree Capital on the acquisition by their Boardriders’ portfolio company of Billabong. The transaction involved the combination of Boardriders’ well-known consumer brands — Quiksilver, Roxy and DC Shoes — with Billabong, creating the world’s largest action sports company. Also acted on the subsequent sale of Boardriders’ to Authentic Brands.
- Olympus Partners on matters including the acquisition by their Liquibox portfolio company of the rigid and flexible packaging business of DS Smith, which was subject to a CMA Phase I remedy.
- Ontario Teachers Pension Plan and Burton's Biscuits Company on the sale of the Cadbury business to Mondelez and on the subsequent sale of Burton’s Biscuits Company to Ferrero Group.
- PSP on the $2 billion acquisition of Hochtief Airports.
- Global Logistics Properties (GLP) on the acquisition of European logistics business IDI Gazeley from Brookfield Asset Management for approximately $2.8 billion.
- Sithe Global Power on the $1.2 billion sale of interests in two coal-fired power plants in The Philippines to Aboitiz Power Corporation.
- Solera, a digital technology group part owned by Vista Equity Partners, on the £340m acquisition of Autodata, a U.K. provider of digital solutions to the automotive industry, which was cleared subject to a CMA Phase I remedy.
- Summit Partners on the sale of Viroclinics-DDL (a virology contract research organization) to Cerba Healthcare and the sale of Independent Vetcare Limited (the third-largest vet services provider in the U.K.) to EQT.
- Thoma Bravo on numerous transactions, including the:
- sale of a significant minority stake in Qlik;
- $2 billion acquisition of Verint Systems;
- $12.3 billion agreement to take Dayforce private;
- $10.55 billion acquisition of digital aviation assets from Boeing.
- Triton on a number of transactions including the carve-out acquisition of the security and communications technology product business from Bosch, the sale of Kelvion to Apollo and the proposed acquisition of the tour operating activities of Corendon and combination with Sunweb (a case subject to referral from the European Commission to Belgium and the Netherlands).
Other Corporate Transactions
Managed required antitrust and FDI approvals for:
- Ardargh Group on a restructuring transaction.
- Intelsat on the $400 million acquisition of the Commercial Aviation Business of Gogo.
- Macquarie Asset Management on the sale of Macquarie Rotorcraft to Sumitomo Mitsui Finance & Leasing and LCI Investment.
News
Engagement & Publications
- Contributor, “Competition Law Update,” Butterworths Journal of International Banking and Financial Law, 2019-25
- Speaker, Thought Leaders 4, Competition Law & Litigation Summer School, 2025
- Contributor, Thought Leaders 4, EU Competition Regulation Circle, 2024
- Contributor, International Cambridge Forum on Antitrust Regulation, June 2023
- Speaker, Lexology/GCR Webinar on UK Merger Control – UK Merger Control Briefing: Latest Trends and Developments, 2022
- Author, “Canon/Toshiba Medical Systems: Questions Raised on the Legitimacy of Warehousing and Further Enforcement of Gun Jumping,” Competition Law Journal, 2020
- Author, “Pooling Arrangements in the Insurance Industry Following Expiry of the Insurance Block Exemption Regulation,” Competition Law Journal, 2017
- Author, regular updates on the EU Foreign Subsidies regime, UK National Security and Investment Act, and annual roundups of antitrust developments
Involvement
- Committee Member, City of London Law Society, Competition Section
- Member, Law Society of England & Wales, Competition Section
- Represented numerous pro bono clients in unpaid wages claims cases